Spravato (esketamine) has possible interactions with alcohol, some other drugs, and certain supplements. Examples include Adderall and benzodiazepines such as clonazepam (Klonopin). Talk with your ...

Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression (TRD) too high to offer value for money, says a US cost-effectiveness body. The Institute for Clinical ...

This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Jessica Mendoza: A quick heads up before we get started. This episode ...

After hours: March 26 at 4:20:00 PM EDT Loading Chart for STEP ...

“If CYB003 can capture even a fraction of Spravato's potential $3-4Bn market share (per street estimates), blockbuster status ...

After hours: March 27 at 7:59:30 PM EDT Loading Chart for JNJ ...

NHS patients with treatment-resistant depression in Scotland will be able to access Johnson & Johnson’s Spravato, a drug that has been turned down twice by NICE for patients in England.

Type 1 diabetes is an autoimmune condition associated with genetics and may develop suddenly. Type 2 diabetes often develops over time, with obesity and a lack of exercise as the main risk factors.

CMPS earnings call for the period ending December 31, 2024. Compass Pathways Plc ( CMPS 7.30%) Q4 2024 Earnings Call Feb 27, 2025, 8:00 a.m. ET ...